Published in Vaccine Weekly, June 22nd, 1998
Under the agreement, Select Therapeutics provides financial support for the collaborative research at both the Institut Curie and the laboratory of Select Therapeutics' principal scientist, Dr. Cliff Lingwood, Research Institute of the Hospital for Sick Children in Toronto, Ontario, Canada. In return, Select Therapeutics...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly